Physician profile
Bryce Wackerle
NPI 1922861335
$493.18
in general payments reported to CMS, 2019-2025
13 companies · $65.72 in 2025
The $65.72 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $427 · 2025: $65.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $493.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $84.06 | 2024 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $77.53 | 2024 | Otezla, Repatha, Prolia |
| Astrazeneca Pharmaceuticals LP | $62.11 | 2024 | Airsupra, Breztri, Farxiga |
| Exact Sciences Corporation | $52.90 | 2024 | Cologuard Collection Kit |
| Medtronic, INC. | $41.31 | 2025 | Nuro, Interstim |
| Lilly USA, LLC | $37.61 | 2024 | Mounjaro |
| Otsuka America Pharmaceutical, INC. | $35.86 | 2024 | Rexulti, Nuedexta |
| Teleflex LLC | $24.41 | 2025 | Barrigel |
| Novartis Pharmaceuticals Corporation | $19.13 | 2024 | |
| Astellas Pharma US INC | $15.31 | 2024 | Veozah |
| Neurocrine Biosciences, INC. | $14.35 | 2024 | Ingrezza |
| Pfizer INC. | $14.31 | 2024 | |
| Glaxosmithkline, LLC. | $14.29 | 2024 | Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryce Wackerle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.